BRIEF-Halozyme Therapeutics Q4 Adjusted EPS USD -0.24 Vs. IBES Estimate USD 2.2
Halozyme Therapeutics, Inc. -2.07%
Halozyme Therapeutics, Inc. HALO | 66.64 | -2.07% |
Feb 17 (Reuters) - Halozyme Therapeutics Q4 EPS USD -1.2.
- Q4 net income USD -141.6 million
- outlook FY revenue USD 1,000 million
